Sirtris: first demonstration in mammals that resveratrol, a sirtuin activator, can treat diseases of aging such as diabetes.
Sirtris Pharmaceuticals doses first diabetes patient in human clinical study with improved formulation of resveratrol
CAMBRIDGE, Mass.–Sirtris Pharmaceuticals, the leading sirtuin therapeutics company, announced today that SRT501, its
Original post by Frank
No comments yet. Be the first.
Leave a reply



















